Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities
Memorial Sloan Kettering Cancer Center · Parker Institute for Cancer Immunotherapy · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
464
total citations
- FWCI
- 25.13
- Percentile
- 100%
- References
- 180
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- Immunotherapy
- Medicine
- Discontinuation
- Cancer
- Pancreatic cancer
- Pancreatic ductal adenocarcinoma
- Cancer immunotherapy
- Oncology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- DRDamon Runyon Cancer Research Foundation
- RARichard and Susan Smith Family Foundation
- BSBristol-Myers Squibb
- AAstraZeneca
- MIMassachusetts Institute of Technology
- UOUniversity of Pennsylvania
- HUHarvard University
- NPNovartis Pharmaceuticals Corporation
- NINational Institutes of HealthAwards: U01 CA224146-01, U01 CA224175-01, R01 CA197916, K12 CA184746-01A1, U01 CA224193-01